[Report: relevance of and indications for submitting surgical specimens to the anatomic pathology laboratory: obstetrics/gynecology and urology]
Bergeron, A
Record ID 32018001742
French
Original Title:
Avis - Pertinence et indications de transmission des prélèvements chirurgicaux au laboratoire d’anatomopathologie : la chirurgie en obstétrique-gynécologie et urologie
Authors' objectives:
Since the publication of the Organization and Management of Institutions Regulation
(C.Q.L.R., chapter S-5, r. 5)1 in 1984, section 59 has generally been interpreted in clinical
circles to mean that all surgical specimens must be sent to the anatomic pathology
laboratory for analysis. This regulatory provision has, for many years, resulted in a large
volume of specimens being submitted and analyzed. It is estimated that a significant
proportion of these submissions may not be necessary.
To promote optimal utilization of anatomic pathology resources and ensure consistency
between institutions, the Ministère de la Santé et des Services sociaux asked the Institut
national d’excellence en santé et en services sociaux (INESSS) to make
recommendations to guide clinicians in their decision to submit or not submit certain
surgical specimens to the anatomic pathology laboratory, based on the anatomical
region, the domain of surgical expertise concerned, and the relevance of an
anatomopathological examination. To this end, the project has been divided into six
parts: orthopedic surgery and neurosurgery, general surgery, plastic surgery and
dermatology (part A); the general surgery subspecialities (part B); obstetrics/gynecology
and urology; cardiovascular and thoracic surgery; otolaryngology and maxillofacial and
cervicofacial surgery; and ophthalmology. The present report deals with
obstetric/gynecologic and urologic surgical specimens.
Authors' results and conclusions:
RESULTS: Based on the scientific literature, there is a low risk of missing a clinically significant
abnormality (i.e., a fortuitous finding that could have an impact on the patient’s
management) in omitting an anatomopathological examination of tissue from a voluntary
termination of pregnancy, a salpingectomy for a benign indication, a circumcision, or an
inguinal hernia repair.
For tissues from a voluntary termination of pregnancy, the sensitivity of an
anatomopathological examination is low for the identification of an abnormal outcome,
including procedural failure, an incomplete procedure or an ectopic pregnancy. The
effectiveness of the surgeon’s examination in predicting an abnormal outcome is, in fact,
greater than that of an examination by the pathologist.
One study found that a histological analysis failed to identify chorionic villi in 4.2% of
ectopic pregnancies confirmed by ultrasound and surgery.
In the case of fallopian tubes, a fortuitous cancer discovery rate of less than 1% is
reported for salpingectomies performed during surgery for benign indications in a
population at low risk for ovarian cancer. For the purpose of this report, consultations with experts on the advisory committee
allowed for the drawing up of a list of obstetric/gynecologic and urologic surgical
specimens for which the level of risk to the patient is considered low. In these cases, an
anatomopathological examination is unlikely to provide useful information for managing
the patient, and the specimens could be submitted to the anatomic pathology laboratory
on a selective basis at the clinician’s discretion. This selective submission list includes:
1) tissues of conception from a normal voluntary termination of pregnancy; 2) rectocele
and cystocele repair tissue; 3) tissues from a labiaplasty; 4) normal-appearing foreskins
from neonates and boys; 5) hydroceles; 6) spermatoceles; 7) varicoceles; 8) urinary
calculi; 9) prostheses, devices, and foreign bodies from the genitourinary sphere; and
10) normal-appearing scars. CONCLUSIONS: The analysis and integration of the data from the scientific literature, the learned society
guidelines and positions, and the perspectives of various stakeholders have enabled
INESSS to make recommendations concerning the selective submission of certain
surgical specimens to the anatomic pathology laboratory. These recommendations
should contribute to more judicious utilization of anatomic pathology resources. However,
the changes to practice that might result from them will depend on the dissemination and
implementation of the recommendations in Québec’s health-care facilities. A gradual
implementation with the councils of physicians, the directors of professional services, the
OPTILAB co-directors and other bodies responsible for the quality of care acting in
concert will be needed to facilitate the changes and ensure optimal management of risk
and of the quality of medical acts.
Authors' methods:
To fulfill the mandate, a systematic review was carried out in the scientific literature and
using publications presenting or containing positions, recommendations or guidance on
the subject. In addition, contextual information and the perspectives of various
stakeholders were gathered to document perceptions of and level of acceptability
associated with the selective submission of certain surgical specimens and materials to
the anatomic pathology laboratory, and to determine the potential organizational, clinical,
ethical and legal issues.
To gather different perspectives, INESSS created an advisory committee consisting of
obstetricians/gynecologists, urologists and anatomic pathologists. In addition, electronic
surveys were sent to the directors of professional services and OPTILAB co-directors (a
clinical laboratory reorganization project) to obtain information on surgical specimen submission practices and anatomic pathology resource utilization in Québec’s healthcare facilities. The Canadian Medical Protective Association was consulted to validate
certain medicolegal issues potentially associated with a change in the procedures for
submitting surgical specimens. Information on the impact of selective submission of
certain surgical specimens on billing and auditing processes was obtained from the
Régie de l’assurance maladie du Québec.
The recommendations concerning obstetric/gynecologic and urologic surgical specimens
that could be submitted to the anatomic pathology laboratory according to a selective
approach are based on a simplified Delphi consultation process with 4 rounds. This
process was carried out with the advisory committee in the light of the data and
information from the systematic literature review and from consultations with informants
and stakeholders, including the aforementioned Canadian Medical Protective Association
and RAMQ
Details
Project Status:
Completed
Year Published:
2021
URL for published report:
https://www.inesss.qc.ca/en/publications/publications/publication/pertinence-et-indications-de-transmission-des-prelevements-chirurgicaux-au-laboratoire-danatomopathologie-la-chirurgie-en-obstetrique-gynecologie-et-urologie.html
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
Canada
Province:
Quebec
MeSH Terms
- Pathology, Surgical
- Biopsy
- Laboratories, Hospital
- Specimen Handling
- General Surgery
- Unnecessary Procedures
- Obstetrics
- Gynecology
- Urology
Contact
Organisation Name:
Institut national d'excellence en sante et en services sociaux
Contact Address:
L'Institut national d'excellence en sante et en services sociaux (INESSS) , 2021, avenue Union, bureau 10.083, Montreal, Quebec, Canada, H3A 2S9;Tel: 1+514-873-2563, Fax: 1+514-873-1369
Contact Name:
demande@inesss.qc.ca
Contact Email:
demande@inesss.qc.ca
Copyright:
Gouvernement du Québec
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.